Anna Rossoshek

National Institutes of Health

Papers

1

Total Citations

49

H-Index

1

About

Dr. Anna Rossoshek is a leading figure in the advancement of in vitro toxicology, with her work fundamentally reshaping how chemical safety is assessed. Her primary research focuses on developing and validating high-throughput screening (HTS) methods to replace traditional, slow, and costly animal studies. Her most-cited paper, "High-Throughput Screening to Advance In Vitro Toxicology" (2023, 49 citations), provides a critical roadmap for the field, systematically analyzing the accomplishments and persistent challenges of HTS. Dr. Rossoshek’s major contribution lies in demonstrating how these rapid, human-cell-based assays can more accurately predict human toxicity, addressing the high rate of drug candidate failure and the growing backlog of untested chemicals. Her work is pivotal in driving the paradigm shift toward more ethical, efficient, and predictive toxicological testing, making her a key voice in the future of chemical safety and drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions
49 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago